Page last updated: 2024-10-31

metoclopramide and Anaplastic Astrocytoma

metoclopramide has been researched along with Anaplastic Astrocytoma in 2 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Research Excerpts

ExcerptRelevanceReference
"3-Chloroprocainamide (3-CPA), an analog of metoclopramide (MCA), dose-dependently inhibited tumor growth in scid mice xenografted with a human brain astrocytoma (T24) when given intramuscularly to mice every third day for 14-20 days."3.69Toxicity, antitumor and chemosensitizing effects of 3-chloroprocainamide. ( Hua, J; Pero, RW, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hua, J2
Olsson, AR1
Pero, RW2

Other Studies

2 other studies available for metoclopramide and Anaplastic Astrocytoma

ArticleYear
Neutral metoclopramide sensitizes cytotoxicity induced by ionizing radiation in SCID mice xenografted with a human brain astrocytoma.
    International journal of cancer, 1997, Dec-10, Volume: 73, Issue:6

    Topics: Animals; Astrocytoma; Blood-Brain Barrier; Body Weight; Brain; Chromatography, High Pressure Liquid;

1997
Toxicity, antitumor and chemosensitizing effects of 3-chloroprocainamide.
    Acta oncologica (Stockholm, Sweden), 1997, Volume: 36, Issue:8

    Topics: Animals; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Cisplatin; Dose-Response Relationship,

1997